Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs 7-05-2024, 18:00
Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024 11-07-2024, 17:30
Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt 21-05-2025, 04:21